Pfizer and biontech announce agreement with the united kingdom for 30 million doses of mrna-based vaccine candidate against sars-cov-2

Pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced an agreement with the united kingdom to supply 30 million doses of their bnt162
BNTX Ratings Summary
BNTX Quant Ranking